In the News

  • Bevacizumab Approved for Platinum-Sensitive Ovarian Cancer in Combination with Chemotherapy
  • Daratumumab Approved in Combination with Standard Regimen for Multiple Myeloma
  • Nivolumab Now Approved for Head and Neck Squamous-Cell Carcinoma
On September 23, 2016, the FDA approved adalimumab-atto (Amjevita; Amgen) as a biosimilar to adalimumab (Humira; AbbVie) for the treatment of several indications and inflammatory diseases in adults, including moderate-to-severe rheumatoid arthritis; psoriatic arthritis; ankylosing spondylitis; moderate-to-severe Crohn’s disease; moderate-to-severe ulcerative colitis; and moderate-to-severe plaque psoriasis.
Page 3 of 12
Results 21 - 30 of 116
  •  Association for Value-Based Cancer Care
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Oncology Practice Management
  • Rheumatology Practice Management
  • Urology Practice Management
  • Inside Patient Care: Pharmacy & Clinic
  • Lynx CME